E.J. Glass. AFRC Institute of Animal Physiology and Genetics Research, Edinburgh Research Station, Roslin, Midlothian, EH25 9PS, U.K.

Similar documents
Edinburgh Research Explorer

Phase of immune response

IMMUNOGENETICS AND TRANSPLANTATION

Basic Immunology. Lecture 5 th and 6 th Recognition by MHC. Antigen presentation and MHC restriction

Transplantation. Immunology Unit College of Medicine King Saud University

HLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol

The Major Histocompatibility Complex (MHC)

IMMUNOGENETICS AND INTRODUCTION TO TRANSPLANTATION

Dissecting Immune Responses. Miriam Windsor, Nicholas Juleff, Mandy Corteyn, Pippa Hamblin, Veronica Carr, Paul V Barnett, Bryan Charleston*

Antigen Presentation to T lymphocytes

Immune responsive role of MHC class II DQA1 gene in livestock

Helminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii. Ringworm fungus HIV Influenza

HLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol

Immunogens and Antigens *

Longevity of the antibody response in pigs and sheep following a single administration of high potency emergency FMD vaccines

HLA and more. Ilias I.N. Doxiadis. Geneva 03/04/2012.

10/18/2012. A primer in HLA: The who, what, how and why. What?

The Immune Epitope Database Analysis Resource: MHC class I peptide binding predictions. Edita Karosiene, Ph.D.

The Human Major Histocompatibility Complex

Histocompatibility antigens

Antigen capture and presentation to T lymphocytes

The Major Histocompatibility Complex

Vaccine Design: A Statisticans Overview

Identification of a novel foot-and-mouth disease virus specific T-cell epitope with immunodominant. characteristics in cattle with MHC serotype A31

Significance of the MHC

Profiling HLA motifs by large scale peptide sequencing Agilent Innovators Tour David K. Crockett ARUP Laboratories February 10, 2009

Two categories of immune response. immune response. infection. (adaptive) Later immune response. immune response

Third line of Defense

The Use of HLA /HPA Selected Platelets

Determinants of Immunogenicity and Tolerance. Abul K. Abbas, MD Department of Pathology University of California San Francisco

Dr. Yi-chi M. Kong August 8, 2001 Benjamini. Ch. 19, Pgs Page 1 of 10 TRANSPLANTATION

Cellular Pathology of immunological disorders

New trends in donor selection in Europe: "best match" versus haploidentical. Prof Jakob R Passweg

Basel - 6 September J.-M. Tiercy National Reference Laboratory for Histocompatibility (LNRH) University Hospital Geneva

25/10/2017. Clinical Relevance of the HLA System in Blood Transfusion. Outline of talk. Major Histocompatibility Complex

Definition of MHC supertypes through clustering of MHC peptide binding repertoires

The Major Histocompatibility Complex of Genes

Antigen processing and presentation. Monika Raulf

Significance of the MHC

The major histocompatibility complex (MHC) is a group of genes that governs tumor and tissue transplantation between individuals of a species.

A HLA-DRB supertype chart with potential overlapping peptide binding function

Antigens and Immunogens

Robert B. Colvin, M.D. Department of Pathology Massachusetts General Hospital Harvard Medical School

Indian Journal of Nephrology Indian J Nephrol 2001;11: 88-97

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS

Breadth of the CD4+ T cell response to Anaplasma marginale VirB9-1, VirB9-2 and VirB10 and MHC class II DR and DQ restriction elements

Foundations in Microbiology

TRANSPLANT IMMUNOLOGY. Shiv Pillai Ragon Institute of MGH, MIT and Harvard

Third line of Defense. Topic 8 Specific Immunity (adaptive) (18) 3 rd Line = Prophylaxis via Immunization!

2017 EFI/DGI Meeting Teaching Session I

Use of BONSAI decision trees for the identification of potential MHC Class I peptide epitope motifs.

Genetics and Genomics in Medicine Chapter 8 Questions

Human Leukocyte Antigens and donor selection

Cover Page. The handle holds various files of this Leiden University dissertation.

XIV. HLA AND TRANSPLANTATION MEDICINE

It s not just allo-antibodies that a red cell transfusion can stimulate

Class I Ag processing. TAP= transporters associated with antigen processing Transport peptides into ER

Clinical Relevance of the HLA System in Blood Transfusion. Dr Colin J Brown PhD FRCPath. October 2017

Histocompatibility Evaluations for HSCT at JHMI. M. Sue Leffell, PhD. Professor of Medicine Laboratory Director

T Cell Development. Xuefang Cao, MD, PhD. November 3, 2015

HLA and disease association

LESSON 2: THE ADAPTIVE IMMUNITY

T Cell Development II: Positive and Negative Selection

the HLA complex Hanna Mustaniemi,

Antigen Recognition by T cells

Defensive mechanisms include :

IMMUNOBIOLOGY, BIOL 537 Exam # 2 Spring 1997

Significance of the MHC

LEO KEI IWAI, 1,3,5 MÁRCIA YOSHIDA, 4 JOHN SIDNEY, 8 MARIA APARECIDA SHIKANAI-YASUDA, 4 ARTICLES INTRODUCTION

HUMAN LEUCOCYTE ANTIGEN (HLA) CLASS I AND II FREQUENCIES IN SELECTED GROUPS IN LEBANON

The Generation of Specific Immunity

T cell-stimulatory fragments of foot-and-mouth disease virus released by mild treatment with cathepsin D

Documentation of Changes to EFI Standards: v 5.6.1

Chapter 15 Adaptive, Specific Immunity and Immunization

FIT Board Review Corner March 2016

α chain β chain C N C N β 2 α 1 β 1 α 2

SINGLE CHOICE. 5. The gamma invariant chain binds to this molecule during its intracytoplasmic transport. A TCR B BCR C MHC II D MHC I E FcγR

M.Sc. III Semester Biotechnology End Semester Examination, 2013 Model Answer LBTM: 302 Advanced Immunology

TCR-p-MHC 10/28/2013. Disclosures. Rheumatoid Arthritis, Psoriatic Arthritis and Autoimmunity: good genes, elegant mechanisms, bad results

DEFINITIONS OF HISTOCOMPATIBILITY TYPING TERMS

RAISON D ETRE OF THE IMMUNE SYSTEM:

Potential cross reactions between HIV 1 specific T cells and the microbiome. Andrew McMichael Suzanne Campion

Innate and Cellular Immunology Control of Infection by Cell-mediated Immunity

They determine if there will be an immune response. Determine functions associated with immune response, but not specific to Ag.

Chapter 22: The Lymphatic System and Immunity

For questions 1-5, match the following with their correct descriptions. (24-39) A. Class I B. Class II C. Class III D. TH1 E. TH2

The MHC and Transplantation Brendan Clark. Transplant Immunology, St James s University Hospital, Leeds, UK

5 Cell recognition and the immune system Support. AQA Biology. Cell recognition and the immune system. Specification reference. Learning objectives

SEVENTH EDITION CHAPTER

MATCHMAKER, MATCHMAKER, MAKE ME A MATCH, FIND ME A MISMATCHED TRANSPLANT TO CATCH

Defining Promiscuous MHC Class II Helper T-Cell Epitopes for the HER2/neu Tumor Antigen 1

The Innate Immune Response

The role of HLA in Allogeneic Hematopoietic Stem Cell Transplantation and Platelet Refractoriness.

The Major Histocompatibility Complex (MHC)

Historical definition of Antigen. An antigen is a foreign substance that elicits the production of antibodies that specifically binds to the antigen.

Tumors arise from accumulated genetic mutations. Tumor Immunology (Cancer)

DIRECT IDENTIFICATION OF NEO-EPITOPES IN TUMOR TISSUE

Generation of the Immune Response

MHC class I MHC class II Structure of MHC antigens:

Immunological response to metallic implants

Transcription:

THE ROLE OF MHC CLASS II IN IMMUNE RESPONSES IN CATTLE E.J. Glass AFRC Institute of Animal Physiology and Genetics Research, Edinburgh Research Station, Roslin, Midlothian, EH25 9PS, U.K. 388 SUMMARY Polymorphism and function of MHC class II molecules in cattle is described. A recently developed method for typing DR-like molecules in cattle - isoelectric focusing - has been used to investigate MHC class II haplotype restriction of bovine antigen specific BoCD4* cell lines. The restriction patterns correlated with the IEF types, at least when ovalbumin was the antigen. The role of these IEF types in immune responsiveness was also investigated using an FMDV derived peptide as the antigen. Although the IEF type influenced the fine specificity of the T cell response, there was no unequivocable evidence for IEF associated Ir gene products. Possibly the response to this peptide is under the control of a further MHC class II locus. INTRODUCTION We are interested in the genetic basis for variation in immune response in cattle as this has important implications for disease resistance/susceptibility and also for molecular vaccine design. One of the obvious areas to investigate is the Major Histocompatibility Complex (MHC) since it plays a central role in the immune system. There are two main groups of MHC molecules - class I and class II and I shall only be considering the latter group. MHC class II molecules are highly polymorphic heterodimeric glycoproteins expressed on the cell surface of antigen presenting cells (APC). T helper (T ) cells only recognise foreign antigen in the form of processed peptides in association with self MHC class II molecules (Schwartz et al., 1986). This phenomenon is referred to as MHC restriction. MHC class II related immune response (Ir) gene effects generally arise because the processed peptides have different binding affinities for different allelic products of MHC class II genes (Guillet et al., 1987). Thus MHC class II molecules are involved in the induction and regulation of most, if not all, immune responses and control both the specificity and strength of these. However, until recently, the bovine MHC class II region was not well characterised - both in terms of its polymorphism and function. It was first defined in cattle as the major locus controlling mixed lymphocyte reactions (MLR) and in families, at least, these specificities were clearly linked to BoLA class I haplotypes (Spooner et al., 1978; Usinger et al., 1981). We have shown that bovine antigen specific T responses are dependent upon MHC class II positive APC (Glass and Spooner, 1989). We have also shown that variation in T cell responses to a multi-epitope molecule, ovalbumin, correlated with BoLA haplotypes in half-sib families, presumably indicating correlation with MHC class II haplotypes (Glass, Oliver and Spooner, 1990a). Thus the interaction between bovine APC and T cells is similar to that described in other species. It would also appear likely that there are bovine immune response genes linked to MHC class II haplotypes. When these experiments were carried out, no MHC class II typing method was available for cattle. However, a one-dimensional isoelectric focusing (IEF) technique for typing DR-like bovine MHC class II products has now been reported (Joosten et al., 1989a). Using this method, these workers in collaboration with our laboratory, identified,

twelve different bovine MHC class II products. Distinct banding patterns for the p chains of each bovine MHC class II product were obtained with two bands per haplotype (Fig. 1). The a chains appeared to be nonpolymorphic. Since then we have detected a further haplotype. We designate the patterns as EDF1 - EDF13 (E for Edinburgh, D in analogy to the human HLA class II system and F for focusing. The numbering system used for EDF types is in PI value sequence and differs from the numbering system of Joosten et al., 1989). Exploiting this method has now enabled us to investigate the relationship between polymorphism and function of MHC class II molecules more extensively than was previously possible. We have investigated MHC class II haplotype restriction of bovine T cells and also expanded our studies on bovine Ir genes. RESULTS AND DISCUSSION For the MHC class II restriction studies, antigen specific T cells were required. In our previous studies we had obtained these directly from peripheral blood mononuclear cells (PBM). However the high frequency of.alloreactive T cells in PBM precluded their use in these studies. Instead ovalbumin specific T cell lines were derived from PBM obtained from high responder animals (Glass and Spooner, 1990). The methodology for generating these lines was essentially similar to that of Kimoto and Fathman (1980) and it selected for antigen specific T cells and depleted alloreactive T cells. The T cell lines were >90% BoCD4* (bovine CD4 equivalent i.e. T phenotype) and were also 20-45% MHC class II positive. Thus activated bovine T cells express MHC class II molecules unlike resting bovine T cells (Glass and Spooner, 1989). This is similar to human and guinea pig T cells (Ko et al., 1979 and Lyons et al., 1981 respectively). Proliferation of these lines to the immunising antigen, ovalbumin in the presence of self APC (irradiated PBM) was highly significant (PcO.OOl) and was dose dependent with a maximum generally reached at 20ug ovalbumin/well. None of the lines responded to ovalbumin in the absence of APC and none responded to an unrelated antigen, human serum albumin. The antigen dependent proliferation was inhibited by several anti bovine MHC class II mononuclear antibodies (mab) but not by anti bovine MHC class I mab. Six of these antigen specific BoCD4* T cell lines were selected for further analysis of their MHC restriction patterns (Glass, Qliver and Spooner, 1990b). The donors of the lines were MHC class II typed by IEF and designated EDF types (Table I). Two of the animals (3 and 4) were apparently homozygous for EDF7 and EDF13 respectively; the other 4 lines were heterozygous (1,2,4 and 6). Thus of the 13 EDF specificities detected so far, 6 are represented within this group. The six cell lines were analysed for responsiveness with a panel of EEF class II typed APC. All of the EDF specificities were represented except EDF 10 which is extremely rare in our population (R.A. Oliver, unpublished observations). The donors were all unrelated except for animals 1-3 which were members of a half-sib family group. An example of the restriction patterns obtained is shown in Fig. 2. The cell line in this case was derived from donor 1, EDF type 6,7. Only APC which shared the EDF6 or 7 haplotype were able to present antigen to BoCD4* cell line 1 and induce significant proliferation (PcO.OOl). No response was observed with APC of any other EDF type. Similar clearcut restriction patterns were obtained with the other 5 BoCD4* cell lines in that they only responded to APC with compatible EDF types (results not shown). The only exception to this was cell line 5 which only responded to antigen in the presence of EDF2 APC and not EDF9 APC. It was also demonstrated that APC would not present antigen to T cell lines if they shared BoLA class I specificities but differed in their EDF class II specificities (data not shown). 389

5/4 7/4 1/8 1/4 6/4 1/4 1/3 1/2 Fig 1. ID-IEF analysis of bovine MHC class II products from eight heterozygous members of a half-sib family group. The EDF haplotypes are shown above the gel. The characteristic banding patterns were designated as shown, based on the findings of Joosten et al. (1989) and R.A. Oliver and J.L. Williams (Unpublished observations). Each animal was given EDF types as indicated with two P bands per haplotype. 390

TABLE 1 Donors from which ovalbumin specific T cell lines were derived Donor 1 2 3 4 5 6 EDF Type 6,7 4,6 7,- 13,- 2,9 2,13 TABLE 2 T cell response by individual cattle to FMDV derived peptides EDF Average Stimulation Index (SI)* Animal class II type FMDV 15 FMDV 19 FMDV 26 1 7,8 58.5 60.4 37.4 2 3,7 29.5 56.5 4.4 3 4,7 41.9 32.5 4.3 4 2,6 39.7 10.2 1.9 5 2,5 35.6 16.1 1.5 6 3,7 16.2 14.1 2.6 7 4,6 22.0 11.5 1.8 8 6,8 17.3 9.1 1.4 9 4,6 8.6 11.1 1.5 10 6,8 8.7 4.9 2.2 11 5,6 5.7 5.4 0.6 12 8,11 4.0 5.7 1.2 13 5,11 4.2 3.0 0.8 *SI = -mean com obtained with peptide mean cpm obtained with medium Background counts were 500 cpm - 3000 cpm FMDV 15 = CC141-158PPS141-158PCG FMDV 19 = 141-158PCG FMDV 26 = 200-213

This study demonstrates that bovine antigen specific CD4* T cells are MHC class II restricted. The results also show that APC from IEF typed unrelated donors can only present antigen if they share at least 1 EDF specificity with the responding cell line. Thus cattle appear to have similar requirements for MHC class II identity between APC and T cell for antigen recognition to occur as has been well documented for other species (Schwartz, 1986; Shevach and Rosenthal, 1973; Bergholtz and Thorsby, 1978). Although these results do not prove identity between the IEF product and the restriction element recognised by the cell lines, it does suggest that the IEF patterns can be used to indicate allelic products relevant to function. The lack of response with EDF9 could be explained in several ways - it could be a nonresponder haplotype or the T cell line may have recognised another MHC class II product not detected by IEF. The only other MHC class II typing method available for cattle at present is restriction fragment length polymorphism (RFLP) analysis (Andersson et al., 1986; Sigurdardottir, Lunden and Andersson, 1988). These workers have shown that there are several DR- and DQ-like genes with considerable polymorphism. The DR and DQ regions appear to be in strong linkage disequilibrium with approximately 30 DR-DQ haplotypes detected. However it is not clear how many of the genes per haplotype are expressed and function as restriction elements although close correlation between these DR-DQ haplotypes and IEF defined haplotypes has been reported (Joosten et al., 1989b). Nonetheless it may be that EDF9 represents a haplotype where (putative) DR and DQ loci are in lower linkage disequilibrium than is the case for other haplotypes. Further work is in progress on these findings. Having established that EDF types are functionally important we used this method to investigate potential MHC class II linked Ir gene effects. We had recently shown that within cattle populations, high and low responders to the multiepitope molecule, ovalbumin, existed and this variation may have been linked to MHC class II polymorphism (Glass, Oliver and Spooner, 1990a). It thus seemed likely that the use of peptide vaccines for cattle may be severely compromised by Ir gene effects. The only potential synthetic peptide vaccine described so far for cattle is against foot and mouth disease virus (FMDV). A synthetic peptide derived from the VPI coat protein of FMDV in the absence of any carrier protein, elicited high levels of neutralising antibody and protected some cattle against challenge (Di Marchi et al., 1986). The most immunogenic part of the FMDV virus appears to be in the loop region, 141,-163 of VPI (for a review see Brown, 1987). In collaboration with T. Collen, T. Doel and K. Murray (AFRC, Institute of Animal Health, U.K.) we have investigated the T cell response to FMDV peptides by a panel of nonrelated Friesian cattle. These were male and approximately 18 months of age to minimise background variations. These animals were MHC class II typed by IEF and from this group we chose 13 animals as shown in Table 2. This group represented as many EDF types as possible but excluded the ones less common in our herd. Each EDF type was also represented at least twice. The animals were all immunised with FMDV15. This 40-mer peptide derived from VPI contains two separate sequences - 141-158 i.e. the immunogenic part, and 200-213, joined by a pro-pro-ser spacer. The 200-213 sequence is capable of inducing low levels of neutralising antibody and in the 3-dimensional structure of native FMDV is next to the 141-158 sequence (Acharya et al., 1989). Lymphocyte transformation assays were performed using PBM, at varying intervals after immunisation. The responses to FMDV 15 by each animal is shown in Table 2. The majority of the blasting cell population was of the T cell phenotype i.e. BoCD4*. Responses varied considerably between animals. Three animals (1, 2 and 3) had consistently low or no responses throughout the experiment (50+ weeks). In fact these three animals only responded to FMDV 15 at loug/ml whereas all the other animals gave 392

A cpm x 10-3 Fig.2 Proliferative response by BoCD4* cell line 1 to a panel of APC (irradiated PBM). This panel included all of the EDF types detected so far (except EDF10). Only the shared EDF types are shown for simplicity. Acpm = cpm in the presence of antigen - cpm with medium alone. Responses = mean of quadruplicate cultures. SD were always less than 10%. 393

significant responses at lower doses. Animals 9-13 had consistently high responses. There is some suggestion that EDF types are involved in the variation in response in that animals with the 5 or 11 EDF type are found at the low end of the range whereas animals with EDF2 or 7 are mainly found at the high end of the response range. Further studies will involve selecting further animals with the EDF5, 11, 2 and 7 haplotypes to see if these initial findings can be confirmed. In order to investigate the fine specificity of the T cell responses, a series of related peptides were also used. The responses to two of these are also shown in Table 2. FMDV19 comprises the immunogenic part, 141-158 plus PCG and FMDV26 comprises the other part of FMDV15 i.e. 200-213. All of the responding animals recognised the 141-158 sequence alone suggesting that there must be a bovine T cell epitope present in this region. In contrast the 200-213 sequence alone elicited low or no response by any of the animals with one major exception - animal 1 - which was also the strongest responder to FMDV15 and FMDV19. FMDV15 specific BoCD4* T cell lines have been generated from some of these animals. The pattern of specificity by these lines mirrors that found with the PBM i.e. the most immunogenic epitope is contained within the 141-158 sequence. MHC class II restriction has also been analysed with these lines. As with ovalbumin specific T cell lines the patterns of response correlate with EDF class II types, with a few notable exceptions. These results may indicate that some of the responses to FMDV peptides are under the control of further bovine MHC class II molecules as yet undetected. Future studies to actively explore these areas are planned. In conclusion the IEF technique has proved a powerful method for studying the relationships between bovine MHC class II polymorphism and function. We have shown that APC - T cell interaction, in cattle, is MHC class II haplotype restricted. MHC class II alleles also appear to play an important role in terms of focusing the fine specificities of response. Their polymorphic nature appears to be implicated in responses to both multiepitope molecules and simpler peptides. All of these factors need to be taken into consideration in the design of synthetic vaccines and probably also for selecting for disease resistance. REFERENCES ACHARYA, R FRY, E., STUART, D FOX, G ROWLANDS, D. AND BROWN, F. 1989. Nature. 337 : 709-716. ANDERSSON, L., BOHME, J RASK, L. AND PETERSON, P.A. Animal Genetics. 17: 95-112. BERGHOLTZ, B.O. AND THORSBY, E. 1978. Scand. J. Immunol. 8 : 63-73. BROWN, F. 1987. In Synthetic Vaccines. Vol. II. Ed. R. Arnon. 65-77. DIMARCHI, R BROOKE, G GALE, C., CRACKNELL, V., DOEL T. and MOWAT, N. 1986. Science. 232 : 639-641. GLASS, E.J. AND SPOONER, R.L. 1989. Res. Vet. Sci. 46 : 196-201. GLASS, E.J., OLIVER, R.A. AND SPOONER, R.L. 1990a. Animal Genetics, in press. GLASS, E.J. AND SPOONER, R.L. 1990. J. Immunol. Methods, in press. GLASS, E.J., OLIVER, R.A. AND SPOONER, R.L. 1990b. Submitted for publication. GU1LLET, J-G., LAI, M.Z., BRINER, T.J., BUUS, S., SETTE, A., GREY, H.M., SMITH, J.A. and GEFTER, M.L. 1987. Science. 235 : 865-870. JOOSTEN, I., SANDERS, M.F., VAN DER POEL, A., WILLIAMS, J.L., HEPKEMA, B.G. and HENSEN, E. 1989a. Immunogenetics. 29 : 213-216. 394

JOOSTEN, I., HENSEN, E.J., SANDERS, M.F. AND ANDERSSON, L. 1989b. Immunobiol. S4 : 101.. KIMOTO, M. AND FATHMAN, C.G. 1980. J. Exp. Med. 152 : 759-770. KO, H-S., FU, S.M., WINCHESTER, R.J., YU, D.T.Y. AND KUNKEL, H.G. 1979. J. Exp. Med. 150 : 246-255. LYONS, C.R., LIPSCOMB, M.F., SCHLOSSMAN, S.F., TUCKER, T.F. AND UHR, J.W. 1981. J. Immunol. 127 : 1879-1885. SCHWARTZ, R. 1986. Adv. Immunol. 38 : 31-201. SHEVACH, E.M. AND ROSENTHAL, A.S. 1973. J. Exp. Med. 138 : 1213-1229. SIGURDARDOTTIR, S LUNDEN, A. AND ANDERSSON, L. 1988. Anim. Genetics. 19 : 133-150. SPOONER, R.L., LEVEZIEL, H GROSCLAUDE, F OLIVER, R.A. AND VAIMAN, M. 1978. J. Immunogenetics. 5 : 335-346. USINGER, W.R., CURIE-COHEN, M BENFORADO, K PRINGNITZ, D REIVE, R SPLITTER, G.A. and STORE, W.H. 1981. Immunogenetics. 14 : 423-428. 395